This episode of 'Conversations in Lung Cancer Research' features Dr. Anna McLean, Dr Mark Adams, and Dr Sagun Parakh, discussing research on the microbiome and its influence on lung cancer treatment outcomes. They delve into the differences between the gut and lung microbiomes, methods for studying these microorganisms, and the potential for the microbiome to serve as biomarkers for treatment response and immune-related adverse events. They also cover the importance of collaboration and larger data sets in advancing this promising area of research.(00:00) Introduction(01:47) Understanding the Microbiome(03:40) Gut and Lung Microbiome Relationship(05:07) Challenges in Lung Microbiome Research(05:37) Microbiome's Role in Lung Cancer Risk(06:57) Techniques for Studying the Microbiome(10:33) Collaborative Efforts in Microbiome Research(16:09) Potential of Microbiome Modulation(20:35) Patient Advice and Future Directions(25:33) Conclusion and Final Thoughts

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related